Study type: Human research · Status: Verified against declared source

Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms

2025

Study scale: Not reported

Abstract only: Open source record

Product or molecular entity relationships

Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

The patient received intravenous Cerebrolysin infusion [7].

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Herpes simplex encephalitis (HSE) is a severe central nervous system (CNS) infection associated with cognitive decline, psychotic symptoms, and epilepsy.

Limitations and uncertainty

Herpes simplex encephalitis (HSE) is a common cause of viral encephalitis that can lead to severe neurological and neuropsychiatric sequelae, including cognitive impairment, epilepsy, and behavioral abnormalities [1,2].

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.